` IRIX (IRIDEX Corp) vs S&P 500 Comparison - Alpha Spread

IRIX
vs
S&P 500

Over the past 12 months, IRIX has underperformed S&P 500, delivering a return of -58% compared to the S&P 500's 11% growth.

Stocks Performance
IRIX vs S&P 500

Loading

Performance Gap
IRIX vs S&P 500

Loading
IRIX
S&P 500
Difference

Performance By Year
IRIX vs S&P 500

Loading
IRIX
S&P 500
Add Stock

Competitors Performance
IRIDEX Corp vs Peers

IRIDEX Corp
Glance View

Market Cap
19.8m USD
Industry
Health Care

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 119 full-time employees. The Company’s laser consoles products consist of Glaucoma, which includes Cyclo G6 laser and delivery devices used for the treatment of glaucoma; Medical Retina product, which includes IQ 532 Laser and IQ 577 Laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases, and its PASCAL Synthesis Photocoagulator for the treatment of retinal diseases; Surgical Retina, which includes OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL and OcuLight GLx laser photocoagulation systems. Its laser probes products consist of Glaucoma, which include MicroPulse P3 Probe, G-Probe and G-Probe Illuminate, and Surgical Retina probes, which include EndoProbe family of products used in vitrectomy procedures.

IRIX Intrinsic Value
2.62 USD
Undervaluation 55%
Intrinsic Value
Price
Back to Top